Keyphrases
Precursor B-cell Acute Lymphoblastic Leukemia
100%
Pediatric
100%
Working Diagnosis
100%
Expression Profiling
100%
Aberrant Expression
75%
Leukemia Patients
50%
MicroRNA
50%
MiR-451
50%
Clinical High Risk
50%
Relapse Risk
50%
MiR-1290
50%
Clinical Outcomes
25%
Quantitative PCR
25%
Low Expression
25%
High-level Expression
25%
Pediatric Patients
25%
Treatment Protocol
25%
Risk Stratification
25%
Cox Regression Analysis
25%
Acute Lymphoblastic Leukemia
25%
High-throughput
25%
Expression Profile
25%
Prognostic Marker
25%
Poor Outcome
25%
Clinical Parameters
25%
Novel Biomarkers
25%
Early Therapy
25%
Relapse-free Survival
25%
Prognostic Relevance
25%
MiRNA Analysis
25%
IKZF1 Deletion
25%
Medicine and Dentistry
Pediatrics
100%
Precursor
100%
Acute B-Cell Lymphoblastic Leukemia
100%
microRNA
75%
Biological Marker
25%
Pediatrics Patient
25%
Proportional Hazards Model
25%
Real-Time Polymerase Chain Reaction
25%
Acute Lymphoblastic Leukemia
25%
Risk Stratification
25%
Recurrence Free Survival
25%
Expression Analysis
25%
Biochemistry, Genetics and Molecular Biology
Precursor
100%
B Cell
100%
Real-Time Polymerase Chain Reaction
25%
MicroRNA
25%
Expression Analysis
25%
IKZF1
25%
Recurrence Free Survival
25%
Immunology and Microbiology
Precursor
100%
B Cell
100%
Real-Time Polymerase Chain Reaction
25%
Recurrence Free Survival
25%
Expression Analysis
25%